div class=ts-pagebutton class=gotoPage data-page=1Page 1button div class=ts-imagea href=https:reader042vdocumentsmxreader042viewer20220309165b65d7e07f8b9a2f5c8c29d4html5page1jpg target=_blank img data-url=modulo-2-lh-stadiazione-e-terapia-di-prima-linea-copia-no-of-ruts-at-riskhtmlpage=1 data-page=1 class=ts-thumb lazyload alt=Page 1: Modulo 2 - LH - Stadiazione e terapia di prima linea copia · No of ruts at Risk 30Gy 20 Gy IFR r groups I and 3 20 Gy IFRT groups 4 at 5 yr -0 5 percentage points 95% Cl loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsmxreader042viewer20220309165b65d7e07f8b9a2f5c8c29d4html5thumbnails1jpg width=140 height=200 adivp1p pIl LINFOMA DI HODGKIN - STADIAZIONE E TERAPIA DI PRIMA LINEApdivdiv class=ts-pagebutton class=gotoPage data-page=2Page 2button div class=ts-imagea href=https:reader042vdocumentsmxreader042viewer20220309165b65d7e07f8b9a2f5c8c29d4html5page2jpg target=_blank img data-url=modulo-2-lh-stadiazione-e-terapia-di-prima-linea-copia-no-of-ruts-at-riskhtmlpage=2 data-page=2 class=ts-thumb lazyload alt=Page 2: Modulo 2 - LH - Stadiazione e terapia di prima linea copia · No of ruts at Risk 30Gy 20 Gy IFR r groups I and 3 20 Gy IFRT groups 4 at 5 yr -0 5 percentage points 95% Cl loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsmxreader042viewer20220309165b65d7e07f8b9a2f5c8c29d4html5thumbnails2jpg width=140 height=200 adivp2p pIl LINFOMA DI HODGKIN - STADIAZIONE E TERAPIA DI PRIMA LINEApdivdiv class=ts-pagebutton class=gotoPage data-page=3Page 3button div class=ts-imagea href=https:reader042vdocumentsmxreader042viewer20220309165b65d7e07f8b9a2f5c8c29d4html5page3jpg target=_blank img data-url=modulo-2-lh-stadiazione-e-terapia-di-prima-linea-copia-no-of-ruts-at-riskhtmlpage=3 data-page=3 class=ts-thumb lazyload alt=Page 3: Modulo 2 - LH - Stadiazione e terapia di prima linea copia · No of ruts at Risk 30Gy 20 Gy IFR r groups I and 3 20 Gy IFRT groups 4 at 5 yr -0 5 percentage points 95% Cl loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsmxreader042viewer20220309165b65d7e07f8b9a2f5c8c29d4html5thumbnails3jpg width=140 height=200 adivp3p pIl LINFOMA DI HODGKIN - STADIAZIONE E TERAPIA DI PRIMA LINEApdivdiv class=ts-pagebutton class=gotoPage data-page=4Page 4button div class=ts-imagea href=https:reader042vdocumentsmxreader042viewer20220309165b65d7e07f8b9a2f5c8c29d4html5page4jpg target=_blank img data-url=modulo-2-lh-stadiazione-e-terapia-di-prima-linea-copia-no-of-ruts-at-riskhtmlpage=4 data-page=4 class=ts-thumb lazyload alt=Page 4: Modulo 2 - LH - Stadiazione e terapia di prima linea copia · No of ruts at Risk 30Gy 20 Gy IFR r groups I and 3 20 Gy IFRT groups 4 at 5 yr -0 5 percentage points 95% Cl loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsmxreader042viewer20220309165b65d7e07f8b9a2f5c8c29d4html5thumbnails4jpg width=140 height=200 adivp4p pIl LINFOMA DI HODGKIN - STADIAZIONE E TERAPIA DI PRIMA LINEApdivdiv class=ts-pagebutton class=gotoPage data-page=5Page 5button div class=ts-imagea href=https:reader042vdocumentsmxreader042viewer20220309165b65d7e07f8b9a2f5c8c29d4html5page5jpg target=_blank img data-url=modulo-2-lh-stadiazione-e-terapia-di-prima-linea-copia-no-of-ruts-at-riskhtmlpage=5 data-page=5 class=ts-thumb lazyload alt=Page 5: Modulo 2 - LH - Stadiazione e terapia di prima linea copia · No of ruts at Risk 30Gy 20 Gy IFR r groups I and 3 20 Gy IFRT groups 4 at 5 yr -0 5 percentage points 95% Cl loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsmxreader042viewer20220309165b65d7e07f8b9a2f5c8c29d4html5thumbnails5jpg width=140 height=200 adivp5p pIl LINFOMA DI HODGKIN - STADIAZIONE E TERAPIA DI PRIMA LINEApdivdiv class=ts-pagebutton class=gotoPage data-page=6Page 6button div class=ts-imagea href=https:reader042vdocumentsmxreader042viewer20220309165b65d7e07f8b9a2f5c8c29d4html5page6jpg target=_blank img data-url=modulo-2-lh-stadiazione-e-terapia-di-prima-linea-copia-no-of-ruts-at-riskhtmlpage=6 data-page=6 class=ts-thumb lazyload alt=Page 6: Modulo 2 - LH - Stadiazione e terapia di prima linea copia · No of ruts at Risk 30Gy 20 Gy IFR r groups I and 3 20 Gy IFRT groups 4 at 5 yr -0 5 percentage points 95% Cl loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsmxreader042viewer20220309165b65d7e07f8b9a2f5c8c29d4html5thumbnails6jpg width=140 height=200 adivp6p pIl LINFOMA DI HODGKIN - STADIAZIONE E TERAPIA DI PRIMA LINEApdivdiv class=ts-pagebutton class=gotoPage data-page=7Page 7button div class=ts-imagea href=https:reader042vdocumentsmxreader042viewer20220309165b65d7e07f8b9a2f5c8c29d4html5page7jpg target=_blank img data-url=modulo-2-lh-stadiazione-e-terapia-di-prima-linea-copia-no-of-ruts-at-riskhtmlpage=7 data-page=7 class=ts-thumb lazyload alt=Page 7: Modulo 2 - LH - Stadiazione e terapia di prima linea copia · No of ruts at Risk 30Gy 20 Gy IFR r groups I and 3 20 Gy IFRT groups 4 at 5 yr -0 5 percentage points 95% Cl loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsmxreader042viewer20220309165b65d7e07f8b9a2f5c8c29d4html5thumbnails7jpg width=140 height=200 adivp7p pIl LINFOMA DI HODGKIN - STADIAZIONE E TERAPIA DI PRIMA LINEApdivdiv class=ts-pagebutton class=gotoPage data-page=8Page 8button div class=ts-imagea href=https:reader042vdocumentsmxreader042viewer20220309165b65d7e07f8b9a2f5c8c29d4html5page8jpg target=_blank img data-url=modulo-2-lh-stadiazione-e-terapia-di-prima-linea-copia-no-of-ruts-at-riskhtmlpage=8 data-page=8 class=ts-thumb lazyload alt=Page 8: Modulo 2 - LH - Stadiazione e terapia di prima linea copia · No of ruts at Risk 30Gy 20 Gy IFR r groups I and 3 20 Gy IFRT groups 4 at 5 yr -0 5 percentage points 95% Cl loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsmxreader042viewer20220309165b65d7e07f8b9a2f5c8c29d4html5thumbnails8jpg width=140 height=200 adivp8p pIl LINFOMA DI HODGKIN - STADIAZIONE E TERAPIA DI PRIMA LINEApdivdiv class=ts-pagebutton class=gotoPage data-page=9Page 9button div class=ts-imagea href=https:reader042vdocumentsmxreader042viewer20220309165b65d7e07f8b9a2f5c8c29d4html5page9jpg target=_blank img data-url=modulo-2-lh-stadiazione-e-terapia-di-prima-linea-copia-no-of-ruts-at-riskhtmlpage=9 data-page=9 class=ts-thumb lazyload alt=Page 9: Modulo 2 - LH - Stadiazione e terapia di prima linea copia · No of ruts at Risk 30Gy 20 Gy IFR r groups I and 3 20 Gy IFRT groups 4 at 5 yr -0 5 percentage points 95% Cl loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsmxreader042viewer20220309165b65d7e07f8b9a2f5c8c29d4html5thumbnails9jpg width=140 height=200 adivp9p pIl LINFOMA DI HODGKIN - STADIAZIONE E TERAPIA DI PRIMA LINEApdivdiv class=ts-pagebutton class=gotoPage data-page=10Page 10button div class=ts-imagea href=https:reader042vdocumentsmxreader042viewer20220309165b65d7e07f8b9a2f5c8c29d4html5page10jpg target=_blank img data-url=modulo-2-lh-stadiazione-e-terapia-di-prima-linea-copia-no-of-ruts-at-riskhtmlpage=10 data-page=10 class=ts-thumb lazyload alt=Page 10: Modulo 2 - LH - Stadiazione e terapia di prima linea copia · No of ruts at Risk 30Gy 20 Gy IFR r groups I and 3 20 Gy IFRT groups 4 at 5 yr -0 5 percentage points 95% Cl loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsmxreader042viewer20220309165b65d7e07f8b9a2f5c8c29d4html5thumbnails10jpg width=140 height=200 adivp10p pIl LINFOMA DI HODGKIN - STADIAZIONE E TERAPIA DI PRIMA LINEApdivdiv class=ts-pagebutton class=gotoPage data-page=11Page 11button div class=ts-imagea href=https:reader042vdocumentsmxreader042viewer20220309165b65d7e07f8b9a2f5c8c29d4html5page11jpg target=_blank img data-url=modulo-2-lh-stadiazione-e-terapia-di-prima-linea-copia-no-of-ruts-at-riskhtmlpage=11 data-page=11 class=ts-thumb lazyload alt=Page 11: Modulo 2 - LH - Stadiazione e terapia di prima linea copia · No of ruts at Risk 30Gy 20 Gy IFR r groups I and 3 20 Gy IFRT groups 4 at 5 yr -0 5 percentage points 95% Cl loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsmxreader042viewer20220309165b65d7e07f8b9a2f5c8c29d4html5thumbnails11jpg width=140 height=200 adivp11p pIl LINFOMA DI HODGKIN - STADIAZIONE E TERAPIA DI PRIMA LINEApdivdiv class=ts-pagebutton class=gotoPage data-page=12Page 12button div class=ts-imagea href=https:reader042vdocumentsmxreader042viewer20220309165b65d7e07f8b9a2f5c8c29d4html5page12jpg target=_blank img data-url=modulo-2-lh-stadiazione-e-terapia-di-prima-linea-copia-no-of-ruts-at-riskhtmlpage=12 data-page=12 class=ts-thumb lazyload alt=Page 12: Modulo 2 - LH - Stadiazione e terapia di prima linea copia · No of ruts at Risk 30Gy 20 Gy IFR r groups I and 3 20 Gy IFRT groups 4 at 5 yr -0 5 percentage points 95% Cl loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsmxreader042viewer20220309165b65d7e07f8b9a2f5c8c29d4html5thumbnails12jpg width=140 height=200 adivp12p pIl LINFOMA DI HODGKIN - STADIAZIONE E TERAPIA DI PRIMA LINEApdivdiv class=ts-pagebutton class=gotoPage data-page=13Page 13button div class=ts-imagea href=https:reader042vdocumentsmxreader042viewer20220309165b65d7e07f8b9a2f5c8c29d4html5page13jpg target=_blank img data-url=modulo-2-lh-stadiazione-e-terapia-di-prima-linea-copia-no-of-ruts-at-riskhtmlpage=13 data-page=13 class=ts-thumb lazyload alt=Page 13: Modulo 2 - LH - Stadiazione e terapia di prima linea copia · No of ruts at Risk 30Gy 20 Gy IFR r groups I and 3 20 Gy IFRT groups 4 at 5 yr -0 5 percentage points 95% Cl loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsmxreader042viewer20220309165b65d7e07f8b9a2f5c8c29d4html5thumbnails13jpg width=140 height=200 adivp13p pIl LINFOMA DI HODGKIN - STADIAZIONE E TERAPIA DI PRIMA LINEApdiv